INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,544 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Option exercise
M—
4,833 sh
Mar 10, 2026Mar 12, 2026
Page 1130 of 1739
← PrevNext →
traded Mar 10, 2026
+2d
SEC Form 4

Evidence

13
AL
Alvarado LuaniChief People Officer
KVUEKenvue Inc.
Option exercise
M—
697 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
RT
Reilly TerenceEVP, Chief Brand Officer
CROXCrocs, Inc.
Tax withholding
F$136K
1,691 sh
Mar 11, 2026Mar 12, 2026
traded Mar 11, 2026
+1dSEC Form 4

Evidence

12
GC
Gallman CariEVP, General Counsel
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
94 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
SW
Short Bartie WendyEVP, Corporate Affairs
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
81 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
CG
Campbell Rupert GeorgeEVP, President of HEYDUDE
CROXCrocs, Inc.
Tax withholding
F$82K
987 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
SE
Sanderson Katherine ElizabethSee Remarks
CDWCDW Corp
Tax withholding
F$77K
645 sh
Mar 12, 2026Mar 12, 2026
traded Mar 12, 2026
+0dSEC Form 4

Evidence

12
MC
Morris Philip CDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$1,069
31 sh
Mar 11, 2026Mar 12, 2026
traded Mar 11, 2026
+1dSEC Form 4

Evidence

12
GC
Gallman CariEVP, General Counsel
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
102 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
HL
Hoch LynellePresident, Cell Therapy Org.
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
113 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
LA
Lenkowsky AdamEVP, Chief Commercial Officer
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
216 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
HM
Holzer Phil MSVP and Controller
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
83 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
HM
Holzer Phil MSVP and Controller
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
91 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
MK
Maersk-Moller KimberlyChief Commercial Officer
MDXGMIMEDX GROUP, INC.
Option exercise
M$193K
42.8K sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
LA
Lenkowsky AdamEVP, Chief Commercial Officer
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
205 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
HL
Hoch LynellePresident, Cell Therapy Org.
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
94 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
MK
Maersk-Moller KimberlyChief Commercial Officer
MDXGMIMEDX GROUP, INC.
Tax withholding
F$96K
21.3K sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
SA
Shea Thomas AnthonyDirector, CEO, 10% Owner
OSOneStream, Inc.
Tax withholding
F$219K
9,258 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
SW
Short Bartie WendyEVP, Corporate Affairs
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
72 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
MK
Mulally Ryan KEVP, Gen'l Counsel, Secretary
DPZDOMINOS PIZZA INC
Tax withholding
F$88K
219 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
DS
Dewan SameerSenior Vice President
GGenpact LTD
Tax withholding
F$138K
3,542 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
PA
Poole Ahn AmandaEVP, Chief People Officer
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
91 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

12
PA
Poole Ahn AmandaEVP, Chief People Officer
BMYBRISTOL MYERS SQUIBB CO
Other acquisition or disposition
J—
87 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

11
MP
McIntyre PamelaChief Accounting Officer
OSOneStream, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
2,015 sh
Mar 11, 2026Mar 12, 2026
traded Mar 11, 2026
+1dSEC Form 4

Evidence

11
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Open-market sale · 10b5-1 plan
SELL$341K
3,908 sh
Mar 11, 2026Mar 12, 2026
traded Mar 11, 2026
+1dSEC Form 4

Evidence

10
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
348 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

10
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Grant or award
A—
16.1K sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

10
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Grant or award
A—
21.8K sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

10
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Grant or award
A—
31.5K sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

9
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Tax withholding
F$3,858
912 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

9
SC
Shibutani Hiroshi ChrisEVP, Chief Strategy Officer
BMYBRISTOL MYERS SQUIBB CO
Grant or award
A—
11.8K sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

9
RB
Raths BarbaraEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$1,375
30 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

9
MK
Mulally Ryan KEVP, Gen'l Counsel, Secretary
DPZDOMINOS PIZZA INC
Tax withholding
F$12K
31 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

9
MS
Mawson SimonSVP, Elec & Spec Materials
SOLSSolstice Advanced Materials Inc.
Grant or award
A—
6 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

9
NK
Ng Wei KingEVP, International
DPZDOMINOS PIZZA INC
Grant or award
A—
2,128 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

9
DH
Dormo Jeffrey HarrisonSVP, Ref. and App. Solutions
SOLSSolstice Advanced Materials Inc.
Grant or award
A—
7 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

9
MS
Mawson SimonSVP, Elec & Spec Materials
SOLSSolstice Advanced Materials Inc.
Grant or award
A—
20 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

9
HL
Hoch LynellePresident, Cell Therapy Org.
BMYBRISTOL MYERS SQUIBB CO
Option exercise
M—
6,304 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

9
SM
Stevens MeredithChief Operations Officer
KVUEKenvue Inc.
Option exercise
M—
4,329 sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence

9
DT
Dworkin TedChief Product Officer
EBEventbrite, Inc.
Disposition to issuer
D—
606.7K sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC Form 4

Evidence